vaccines
India Develops First Indigenous Rotavirus Vaccine
The Government of India and Bharat Biotech have announced positive Phase III results from India's first indigenous, low-priced rotavirus vaccine.
H1N1 Influenza Vaccine From A*STAR & Cytos Enters Phase I Trials
Singapore's A*STAR and Switzerland's Cytos Biotechnology AG today announced the initiation of Phase I trials for their H1N1 influenza vaccine candidate.
Researchers Engineer Potent Antibody Against Dengue Virus
Researchers from Singapore and the U.S. have engineered a potent antibody against the dengue virus.
WHO: Everything You Need To Know About The H7N9 Influenza Virus
The World Health Organization has released a FAQ list answering some questions relating to the H7N9 influenza A virus outbreak in China.
Sanofi Pasteur, Xiamen University To Develop Universal Flu Vaccine
Sanofi Pasteur and Xiamen University in China have agreed to jointly develop a universal flu vaccine.
Study’s Asian Dengue Estimates Are Too Low, Says Expert
An expert says that fresh estimates of the number of cases of dengue fever in South-East Asia and one country in South Asia are too low.
Takeda Submits NDA Application For Cell Culture-Based H5N1 Vaccines
Takeda Pharma has submitted New Drug Applications for cell culture-based H5N1 influenza vaccines to the Ministry of Health, Labor and Welfare in Japan.
Sinovac Reports PhIII Trial Results For HFMD Vaccine Candidate
Chinese vaccine provider Sinovac Biotech Ltd. has completed a Phase III clinical trial on its Enterovirus 71 vaccine against hand, foot, and mouth disease.
Inviragen Advances Dengue Vaccine Into Second Stage Of Phase II Study
Inviragen, Inc. has initiated the second stage of an ongoing Phase II study of DENVax™, its investigational dengue vaccine.
